AWARENESS AND KNOWLEDGE SHARING AMONG PHYSICIANS REGARDING INFLUENZA AND PNEUMOCOCCAL VACCINES FOR CARDIOVASCULAR PATIENTS
| dc.contributor.author | Shaikh, Naveed Ahmed | |
| dc.contributor.author | Talpur, Mir Fahad Hussain | |
| dc.contributor.author | Shah, Shahbaz Ali | |
| dc.contributor.author | Kumar, Rajesh | |
| dc.contributor.author | Bhatti, Khalid Iqbal | |
| dc.contributor.author | Ashraf, Tariq | |
| dc.contributor.author | Samad, Ayesha | |
| dc.contributor.author | Hussain, Syed Taimour | |
| dc.date.accessioned | 2026-09-05T09:14:54Z | |
| dc.date.copyright | 2022 | |
| dc.date.issued | 2022-03-25 | |
| dc.description.abstract | Objectives: We conducted this survey to evaluate the knowledge of cardiologists, internists, and family physicians regarding influenza and pneumonia vaccination among cardiovascular disease (CVD) patients. Methodology: An online survey was conducted including practicing cardiologist, internists, and family physicians at various positions working in tertiary health care centres of all major hospitals in all over the Pakistan. A structured questionnaire was designed to assess the physicians’ knowledge toward influenza and pneumococcal vaccine and barriers for prescribing it to the recommended CVD patients. Results: A total of 380 physicians participated in this survey, out of which 58.9% (224) were male and majority 96.3% (366) were ≤ 40 years of age. A 82.6% (314) participants indorsed that the pneumococcal vaccine is Class I indication in cardiac patients above 65 years of age, while, 48.2% (183) considered it to be recommended by the ACC/AHA in all age groups of cardiac patients. Pneumococcal vaccine are considered to be live attenuated vaccines by the 41.8% (159) of the participants. The mean knowledge score was found to be 63.09 ± 13.61. The most common stated reasons for not prescribing pneumococcal vaccine was not readily available, 42.9% (42), followed by the perception that it is not indicated, 36.7% (36). Conclusion: Most of the physicians were not thoroughly well-aware about indications of the vaccine in CVD patients. Additionally, scope of the vaccine is under-estimated because of lack of knowledge regarding importance of vaccine and secondly due to unavailability of vaccine in most of the areas of Pakistan. | |
| dc.format.extent | pp. 10-14 | |
| dc.identifier.citation | Pakistan Heart Journal; Vol. 55 No. 1 (2022), pp. 10-14 | |
| dc.identifier.doi | 10.47144/phj.v55i1.2194 | |
| dc.identifier.uri | https://pakheartjournal.com/index.php/pk/article/view/2194 | |
| dc.identifier.uri | https://ds.pakheartjournal.com/handle/phj/793 | |
| dc.language.iso | en | |
| dc.publisher | Pakistan Heart Journal | |
| dc.relation.ispartofseries | Pakistan Heart Journal; Vol. 55 No. 1 (2022) | |
| dc.rights.holder | Pakistan Heart Journal | |
| dc.title | AWARENESS AND KNOWLEDGE SHARING AMONG PHYSICIANS REGARDING INFLUENZA AND PNEUMOCOCCAL VACCINES FOR CARDIOVASCULAR PATIENTS | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2194-1-7710-2-10-20220413.pdf
- Size:
- 364.96 KB
- Format:
- Adobe Portable Document Format